FluidForm Bio™ Announces Participation at Biotech Showcase and the 14th Annual LifeSci Partners Corporate Access Event

WALTHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced that Mike Graffeo, CEO and co-founder, will deliver a company overview and conduct one-on-one meetings at Biotech Showcase, which is being held January 13-15, in San Francisco. Details of the presentation are as follows:Date: Wednesday, January 15thTime: 9:45am PT In addition to a corporate update, FluidForm will share updated data on its lead program in ...